Clinical trials: Psychological

Dyspareunia

Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy

• Completed
• Age: 40 to 75 years
• Phase 3
• Results posted

Randomized, double-blind, placebo-controlled, parallel-designed, multiple-site, bioequivalence study with clinical endpoints.

Trial name

NCT05617820

Testing

Estradiol, Imvexxy

Where

48 sites in United States, El Salvador and 1 more

Volunteers

1,050 people, healthy volunteers welcome

Sponsor

Teva Pharmaceuticals USA